論文

国際誌
2022年11月8日

Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation.

Circulation
  • Koshiro Kanaoka
  • Kenji Onoue
  • Satoshi Terasaki
  • Tomoya Nakano
  • Michikazu Nakai
  • Yoko Sumita
  • Kinta Hatakeyama
  • Fumio Terasaki
  • Rika Kawakami
  • Yoshitaka Iwanaga
  • Yoshihiro Miyamoto
  • Yoshihiko Saito
  • 全て表示

146
19
開始ページ
1425
終了ページ
1433
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1161/CIRCULATIONAHA.121.058869

BACKGROUND: Fulminant myocarditis presentation (FMP) is a rare and severe presentation of myocarditis. The natural history of FMP and its clinical features associated with poor outcomes are incompletely understood because there is a lack of generalizable evidence. METHODS: This multicenter retrospective cohort study included patients hospitalized with histologically proven myocarditis who underwent catecholamine or mechanical support from 235 cardiovascular training hospitals across Japan between April 2012 and March 2017. Clinical features and the prognostic predictors of death or heart transplantation within 90 days on the basis of clinical and pathologic findings were determined using the Kaplan-Meier method, log-rank test, and Cox regression analysis. RESULTS: This study included 344 patients with histologically proven FMP (median age, 54 years; 40% female). The median follow-up was 600 days (interquartile range, 36 to 1599 days) and the cumulative risk of death or heart transplantation at 90 days was 29% (n=98). Results from multivariable Cox regression analysis showed that older age, nonsinus rhythm, low left ventricular wall motion (<40%) on admission, and ventricular tachycardia or fibrillation on admission day were associated with worse 90-day survival. Severe histologic damage (damaged cardiomyocytes comprising ≥50% of the total cardiomyocytes) was associated with a worse 90-day prognosis in patients with lymphocytic myocarditis. CONCLUSIONS: The results from analyses of data from this multicenter registry demonstrated that patients with FMP are at a higher risk of death or heart transplantation in real-world settings. These observations inform which clinical and pathologic findings may be useful for prognostication in FMP. REGISTRATION: URL: https://www.umin.ac.jp/ctr; Unique identifier: UMIN000039763.

リンク情報
DOI
https://doi.org/10.1161/CIRCULATIONAHA.121.058869
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/36164974
ID情報
  • DOI : 10.1161/CIRCULATIONAHA.121.058869
  • ORCIDのPut Code : 121073520
  • PubMed ID : 36164974

エクスポート
BibTeX RIS